FDA Inspection 1256937 — OsteoLife Biomedical, LLC
The FDA completed an inspection of OsteoLife Biomedical, LLC on December 11, 2024 in Jupiter, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 11, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Jupiter, FL (United States)